DMSO and colchicine therapy in amyloid disease

M. A. Scheinberg, J. C. Pernambuco, Merrill Benson

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

There is no specific therapy for primary amyloidosis, and acquired generalised amyloidosis can be treated only if the underlying disease is eliminated. In this study we have investigated the role of colchicine therapy in primary amyloidosis, and dimethylsulphoxide (DMSO) in leprosy associated secondary amyloidosis. No effect on creatinine clearance or 24 h proteinuria could be observed in the patients with primary amyloidosis. In the DMSO group renal function was considerably improved in 3 patients with moderate renal failure but not in those with severe renal impairment (creatinine clearance <10 ml/min). Serum SAA determinations were not particularly informative. These findings point to a beneficial effect of DMSO in human secondary amyloidosis when given at an early stage of renal involvement.

Original languageEnglish (US)
Pages (from-to)421-423
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume43
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Colchicine
Amyloidosis
Dimethyl Sulfoxide
Amyloid
Kidney
Creatinine
Leprosy
Proteinuria
Renal Insufficiency
Therapeutics
Serum
Primary amyloidosis

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Scheinberg, M. A., Pernambuco, J. C., & Benson, M. (1984). DMSO and colchicine therapy in amyloid disease. Annals of the Rheumatic Diseases, 43(3), 421-423.

DMSO and colchicine therapy in amyloid disease. / Scheinberg, M. A.; Pernambuco, J. C.; Benson, Merrill.

In: Annals of the Rheumatic Diseases, Vol. 43, No. 3, 1984, p. 421-423.

Research output: Contribution to journalArticle

Scheinberg, MA, Pernambuco, JC & Benson, M 1984, 'DMSO and colchicine therapy in amyloid disease', Annals of the Rheumatic Diseases, vol. 43, no. 3, pp. 421-423.
Scheinberg, M. A. ; Pernambuco, J. C. ; Benson, Merrill. / DMSO and colchicine therapy in amyloid disease. In: Annals of the Rheumatic Diseases. 1984 ; Vol. 43, No. 3. pp. 421-423.
@article{9dd3a7f198ca477a8e4b8e764db937db,
title = "DMSO and colchicine therapy in amyloid disease",
abstract = "There is no specific therapy for primary amyloidosis, and acquired generalised amyloidosis can be treated only if the underlying disease is eliminated. In this study we have investigated the role of colchicine therapy in primary amyloidosis, and dimethylsulphoxide (DMSO) in leprosy associated secondary amyloidosis. No effect on creatinine clearance or 24 h proteinuria could be observed in the patients with primary amyloidosis. In the DMSO group renal function was considerably improved in 3 patients with moderate renal failure but not in those with severe renal impairment (creatinine clearance <10 ml/min). Serum SAA determinations were not particularly informative. These findings point to a beneficial effect of DMSO in human secondary amyloidosis when given at an early stage of renal involvement.",
author = "Scheinberg, {M. A.} and Pernambuco, {J. C.} and Merrill Benson",
year = "1984",
language = "English (US)",
volume = "43",
pages = "421--423",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - DMSO and colchicine therapy in amyloid disease

AU - Scheinberg, M. A.

AU - Pernambuco, J. C.

AU - Benson, Merrill

PY - 1984

Y1 - 1984

N2 - There is no specific therapy for primary amyloidosis, and acquired generalised amyloidosis can be treated only if the underlying disease is eliminated. In this study we have investigated the role of colchicine therapy in primary amyloidosis, and dimethylsulphoxide (DMSO) in leprosy associated secondary amyloidosis. No effect on creatinine clearance or 24 h proteinuria could be observed in the patients with primary amyloidosis. In the DMSO group renal function was considerably improved in 3 patients with moderate renal failure but not in those with severe renal impairment (creatinine clearance <10 ml/min). Serum SAA determinations were not particularly informative. These findings point to a beneficial effect of DMSO in human secondary amyloidosis when given at an early stage of renal involvement.

AB - There is no specific therapy for primary amyloidosis, and acquired generalised amyloidosis can be treated only if the underlying disease is eliminated. In this study we have investigated the role of colchicine therapy in primary amyloidosis, and dimethylsulphoxide (DMSO) in leprosy associated secondary amyloidosis. No effect on creatinine clearance or 24 h proteinuria could be observed in the patients with primary amyloidosis. In the DMSO group renal function was considerably improved in 3 patients with moderate renal failure but not in those with severe renal impairment (creatinine clearance <10 ml/min). Serum SAA determinations were not particularly informative. These findings point to a beneficial effect of DMSO in human secondary amyloidosis when given at an early stage of renal involvement.

UR - http://www.scopus.com/inward/record.url?scp=0021179772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021179772&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 421

EP - 423

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 3

ER -